img

Global Radiopharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Radiopharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Radiopharmaceuticals report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Radiopharmaceuticals market is projected to reach US$ 11660 million in 2034, increasing from US$ 6761 million in 2022, with the CAGR of 8.0% during the period of 2024 to 2034. Demand from Oncology and Cardiology are the major drivers for the industry.
The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Radiopharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Segment by Type
Diagnostic Radioisotopes
Therapeutic Radioisotopes

Segment by Application


Oncology
Cardiology
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Radiopharmaceuticals market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Radiopharmaceuticals, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Radiopharmaceuticals industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Radiopharmaceuticals in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Radiopharmaceuticals introduction, etc. Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Radiopharmaceuticals market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Radiopharmaceuticals Market Overview
1.1 Radiopharmaceuticals Product Overview
1.2 Radiopharmaceuticals Market Segment by Type
1.2.1 Diagnostic Radioisotopes
1.2.2 Therapeutic Radioisotopes
1.3 Global Radiopharmaceuticals Market Size by Type
1.3.1 Global Radiopharmaceuticals Market Size Overview by Type (2018-2034)
1.3.2 Global Radiopharmaceuticals Historic Market Size Review by Type (2018-2024)
1.3.3 Global Radiopharmaceuticals Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Radiopharmaceuticals Sales Breakdown by Type (2018-2024)
1.4.2 Europe Radiopharmaceuticals Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Radiopharmaceuticals Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Radiopharmaceuticals Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Radiopharmaceuticals Sales Breakdown by Type (2018-2024)
2 Global Radiopharmaceuticals Market Competition by Company
2.1 Global Top Players by Radiopharmaceuticals Sales (2018-2024)
2.2 Global Top Players by Radiopharmaceuticals Revenue (2018-2024)
2.3 Global Top Players by Radiopharmaceuticals Price (2018-2024)
2.4 Global Top Manufacturers Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type
2.5 Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Radiopharmaceuticals Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Radiopharmaceuticals Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2022)
2.7 Date of Key Manufacturers Enter into Radiopharmaceuticals Market
2.8 Key Manufacturers Radiopharmaceuticals Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Radiopharmaceuticals Status and Outlook by Region
3.1 Global Radiopharmaceuticals Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Radiopharmaceuticals Historic Market Size by Region
3.2.1 Global Radiopharmaceuticals Sales in Volume by Region (2018-2024)
3.2.2 Global Radiopharmaceuticals Sales in Value by Region (2018-2024)
3.2.3 Global Radiopharmaceuticals Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Radiopharmaceuticals Forecasted Market Size by Region
3.3.1 Global Radiopharmaceuticals Sales in Volume by Region (2024-2034)
3.3.2 Global Radiopharmaceuticals Sales in Value by Region (2024-2034)
3.3.3 Global Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Radiopharmaceuticals by Application
4.1 Radiopharmaceuticals Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Other
4.2 Global Radiopharmaceuticals Market Size by Application
4.2.1 Global Radiopharmaceuticals Market Size Overview by Application (2018-2034)
4.2.2 Global Radiopharmaceuticals Historic Market Size Review by Application (2018-2024)
4.2.3 Global Radiopharmaceuticals Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Radiopharmaceuticals Sales Breakdown by Application (2018-2024)
4.3.2 Europe Radiopharmaceuticals Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Radiopharmaceuticals Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Radiopharmaceuticals Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Radiopharmaceuticals Sales Breakdown by Application (2018-2024)
5 North America Radiopharmaceuticals by Country
5.1 North America Radiopharmaceuticals Historic Market Size by Country
5.1.1 North America Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Radiopharmaceuticals Sales in Volume by Country (2018-2024)
5.1.3 North America Radiopharmaceuticals Sales in Value by Country (2018-2024)
5.2 North America Radiopharmaceuticals Forecasted Market Size by Country
5.2.1 North America Radiopharmaceuticals Sales in Volume by Country (2024-2034)
5.2.2 North America Radiopharmaceuticals Sales in Value by Country (2024-2034)
6 Europe Radiopharmaceuticals by Country
6.1 Europe Radiopharmaceuticals Historic Market Size by Country
6.1.1 Europe Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Radiopharmaceuticals Sales in Volume by Country (2018-2024)
6.1.3 Europe Radiopharmaceuticals Sales in Value by Country (2018-2024)
6.2 Europe Radiopharmaceuticals Forecasted Market Size by Country
6.2.1 Europe Radiopharmaceuticals Sales in Volume by Country (2024-2034)
6.2.2 Europe Radiopharmaceuticals Sales in Value by Country (2024-2034)
7 Asia-Pacific Radiopharmaceuticals by Region
7.1 Asia-Pacific Radiopharmaceuticals Historic Market Size by Region
7.1.1 Asia-Pacific Radiopharmaceuticals Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Radiopharmaceuticals Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Radiopharmaceuticals Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Radiopharmaceuticals Forecasted Market Size by Region
7.2.1 Asia-Pacific Radiopharmaceuticals Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Radiopharmaceuticals Sales in Value by Region (2024-2034)
8 Latin America Radiopharmaceuticals by Country
8.1 Latin America Radiopharmaceuticals Historic Market Size by Country
8.1.1 Latin America Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Radiopharmaceuticals Sales in Volume by Country (2018-2024)
8.1.3 Latin America Radiopharmaceuticals Sales in Value by Country (2018-2024)
8.2 Latin America Radiopharmaceuticals Forecasted Market Size by Country
8.2.1 Latin America Radiopharmaceuticals Sales in Volume by Country (2024-2034)
8.2.2 Latin America Radiopharmaceuticals Sales in Value by Country (2024-2034)
9 Middle East and Africa Radiopharmaceuticals by Country
9.1 Middle East and Africa Radiopharmaceuticals Historic Market Size by Country
9.1.1 Middle East and Africa Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Radiopharmaceuticals Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Radiopharmaceuticals Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Radiopharmaceuticals Forecasted Market Size by Country
9.2.1 Middle East and Africa Radiopharmaceuticals Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Radiopharmaceuticals Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bracco Imaging
10.1.1 Bracco Imaging Company Information
10.1.2 Bracco Imaging Introduction and Business Overview
10.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bracco Imaging Radiopharmaceuticals Products Offered
10.1.5 Bracco Imaging Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bayer Radiopharmaceuticals Products Offered
10.2.5 Bayer Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Company Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Mallinckrodt Radiopharmaceuticals Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Nordion
10.4.1 Nordion Company Information
10.4.2 Nordion Introduction and Business Overview
10.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Nordion Radiopharmaceuticals Products Offered
10.4.5 Nordion Recent Development
10.5 Triad Isotopes
10.5.1 Triad Isotopes Company Information
10.5.2 Triad Isotopes Introduction and Business Overview
10.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Triad Isotopes Radiopharmaceuticals Products Offered
10.5.5 Triad Isotopes Recent Development
10.6 Lantheus
10.6.1 Lantheus Company Information
10.6.2 Lantheus Introduction and Business Overview
10.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Lantheus Radiopharmaceuticals Products Offered
10.6.5 Lantheus Recent Development
10.7 IBA Group
10.7.1 IBA Group Company Information
10.7.2 IBA Group Introduction and Business Overview
10.7.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.7.4 IBA Group Radiopharmaceuticals Products Offered
10.7.5 IBA Group Recent Development
10.8 GE Healthcare
10.8.1 GE Healthcare Company Information
10.8.2 GE Healthcare Introduction and Business Overview
10.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.8.4 GE Healthcare Radiopharmaceuticals Products Offered
10.8.5 GE Healthcare Recent Development
10.9 China Isotope & Radiation
10.9.1 China Isotope & Radiation Company Information
10.9.2 China Isotope & Radiation Introduction and Business Overview
10.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.9.4 China Isotope & Radiation Radiopharmaceuticals Products Offered
10.9.5 China Isotope & Radiation Recent Development
10.10 Jubilant Pharma
10.10.1 Jubilant Pharma Company Information
10.10.2 Jubilant Pharma Introduction and Business Overview
10.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Jubilant Pharma Radiopharmaceuticals Products Offered
10.10.5 Jubilant Pharma Recent Development
10.11 Eli Lilly
10.11.1 Eli Lilly Company Information
10.11.2 Eli Lilly Introduction and Business Overview
10.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Eli Lilly Radiopharmaceuticals Products Offered
10.11.5 Eli Lilly Recent Development
10.12 Advanced Accelerator Applications
10.12.1 Advanced Accelerator Applications Company Information
10.12.2 Advanced Accelerator Applications Introduction and Business Overview
10.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Advanced Accelerator Applications Radiopharmaceuticals Products Offered
10.12.5 Advanced Accelerator Applications Recent Development
10.13 SIEMENS
10.13.1 SIEMENS Company Information
10.13.2 SIEMENS Introduction and Business Overview
10.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.13.4 SIEMENS Radiopharmaceuticals Products Offered
10.13.5 SIEMENS Recent Development
10.14 Dongcheng
10.14.1 Dongcheng Company Information
10.14.2 Dongcheng Introduction and Business Overview
10.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Dongcheng Radiopharmaceuticals Products Offered
10.14.5 Dongcheng Recent Development
10.15 Navidea
10.15.1 Navidea Company Information
10.15.2 Navidea Introduction and Business Overview
10.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Navidea Radiopharmaceuticals Products Offered
10.15.5 Navidea Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Radiopharmaceuticals Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Radiopharmaceuticals Industrial Chain Analysis
11.4 Radiopharmaceuticals Market Dynamics
11.4.1 Radiopharmaceuticals Industry Trends
11.4.2 Radiopharmaceuticals Market Drivers
11.4.3 Radiopharmaceuticals Market Challenges
11.4.4 Radiopharmaceuticals Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Radiopharmaceuticals Distributors
12.3 Radiopharmaceuticals Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Diagnostic Radioisotopes
Table 2. Major Company of Therapeutic Radioisotopes
Table 3. Global Radiopharmaceuticals Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Radiopharmaceuticals Sales by Type (2018-2024) & (K Units)
Table 5. Global Radiopharmaceuticals Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Radiopharmaceuticals Sales by Type (2018-2024) & (US& Million)
Table 7. Global Radiopharmaceuticals Market Share in Value by Type (2018-2024)
Table 8. Global Radiopharmaceuticals Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Radiopharmaceuticals Sales by Type (2024-2034) & (K Units)
Table 10. Global Radiopharmaceuticals Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Radiopharmaceuticals Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Radiopharmaceuticals Sales Market Share in Value by Type (2024-2034)
Table 13. Global Radiopharmaceuticals Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Radiopharmaceuticals Sales by Type (2018-2024) & (K Units)
Table 15. North America Radiopharmaceuticals Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Radiopharmaceuticals Sales (K Units) by Type (2018-2024)
Table 17. Europe Radiopharmaceuticals Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Radiopharmaceuticals Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Radiopharmaceuticals Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Radiopharmaceuticals Sales (K Units) by Type (2018-2024)
Table 21. Latin America Radiopharmaceuticals Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Radiopharmaceuticals Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Radiopharmaceuticals Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Radiopharmaceuticals Sales by Company (2018-2024) & (K Units)
Table 25. Global Radiopharmaceuticals Sales Share by Company (2018-2024)
Table 26. Global Radiopharmaceuticals Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Radiopharmaceuticals Revenue Share by Company (2018-2024)
Table 28. Global Market Radiopharmaceuticals Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Radiopharmaceuticals Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2022)
Table 32. Date of Key Manufacturers Enter into Radiopharmaceuticals Market
Table 33. Key Manufacturers Radiopharmaceuticals Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Radiopharmaceuticals Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Radiopharmaceuticals Sales by Region (2018-2024) & (K Units)
Table 37. Global Radiopharmaceuticals Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Radiopharmaceuticals Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Radiopharmaceuticals Sales Market Share in Value by Region (2018-2024)
Table 40. Global Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Radiopharmaceuticals Sales by Region (2024-2034) & (K Units)
Table 42. Global Radiopharmaceuticals Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Radiopharmaceuticals Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Radiopharmaceuticals Sales Market Share in Value by Region (2024-2034)
Table 45. Global Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Radiopharmaceuticals Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Radiopharmaceuticals Sales by Application (2018-2024) & (K Units)
Table 48. Global Radiopharmaceuticals Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Radiopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Radiopharmaceuticals Sales Market Share in Value by Application (2018-2024)
Table 51. Global Radiopharmaceuticals Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Radiopharmaceuticals Sales by Application (2024-2034) & (K Units)
Table 53. Global Radiopharmaceuticals Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Radiopharmaceuticals Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Radiopharmaceuticals Sales Market Share in Value by Application (2024-2034)
Table 56. Global Radiopharmaceuticals Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Radiopharmaceuticals Sales by Application (2018-2024) (K Units)
Table 58. North America Radiopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Radiopharmaceuticals Sales by Application (2018-2024) (K Units)
Table 60. Europe Radiopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Radiopharmaceuticals Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Radiopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Radiopharmaceuticals Sales by Application (2018-2024) (K Units)
Table 64. Latin America Radiopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Radiopharmaceuticals Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Radiopharmaceuticals Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Radiopharmaceuticals Sales by Country (2018-2024) & (K Units)
Table 68. North America Radiopharmaceuticals Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Radiopharmaceuticals Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Radiopharmaceuticals Sales Market Share in Value by Country (2018-2024)
Table 71. North America Radiopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 72. North America Radiopharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Radiopharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Radiopharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Radiopharmaceuticals Sales by Country (2018-2024) & (K Units)
Table 76. Europe Radiopharmaceuticals Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Radiopharmaceuticals Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Radiopharmaceuticals Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Radiopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 80. Europe Radiopharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Radiopharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Radiopharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Radiopharmaceuticals Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Radiopharmaceuticals Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Radiopharmaceuticals Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Radiopharmaceuticals Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Radiopharmaceuticals Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Radiopharmaceuticals Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Radiopharmaceuticals Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Radiopharmaceuticals Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Radiopharmaceuticals Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Radiopharmaceuticals Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Radiopharmaceuticals Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Radiopharmaceuticals Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Radiopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Radiopharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Radiopharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Radiopharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Radiopharmaceuticals Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Radiopharmaceuticals Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Radiopharmaceuticals Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Radiopharmaceuticals Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Radiopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Radiopharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Radiopharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Radiopharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 107. Bracco Imaging Company Information
Table 108. Bracco Imaging Introduction and Business Overview
Table 109. Bracco Imaging Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Bracco Imaging Radiopharmaceuticals Product
Table 111. Bracco Imaging Recent Development
Table 112. Bayer Company Information
Table 113. Bayer Introduction and Business Overview
Table 114. Bayer Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Bayer Radiopharmaceuticals Product
Table 116. Bayer Recent Development
Table 117. Mallinckrodt Company Information
Table 118. Mallinckrodt Introduction and Business Overview
Table 119. Mallinckrodt Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Mallinckrodt Radiopharmaceuticals Product
Table 121. Mallinckrodt Recent Development
Table 122. Nordion Company Information
Table 123. Nordion Introduction and Business Overview
Table 124. Nordion Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Nordion Radiopharmaceuticals Product
Table 126. Nordion Recent Development
Table 127. Triad Isotopes Company Information
Table 128. Triad Isotopes Introduction and Business Overview
Table 129. Triad Isotopes Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Triad Isotopes Radiopharmaceuticals Product
Table 131. Triad Isotopes Recent Development
Table 132. Lantheus Company Information
Table 133. Lantheus Introduction and Business Overview
Table 134. Lantheus Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Lantheus Radiopharmaceuticals Product
Table 136. Lantheus Recent Development
Table 137. IBA Group Company Information
Table 138. IBA Group Introduction and Business Overview
Table 139. IBA Group Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. IBA Group Radiopharmaceuticals Product
Table 141. IBA Group Recent Development
Table 142. GE Healthcare Company Information
Table 143. GE Healthcare Introduction and Business Overview
Table 144. GE Healthcare Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. GE Healthcare Radiopharmaceuticals Product
Table 146. GE Healthcare Recent Development
Table 147. China Isotope & Radiation Company Information
Table 148. China Isotope & Radiation Introduction and Business Overview
Table 149. China Isotope & Radiation Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. China Isotope & Radiation Radiopharmaceuticals Product
Table 151. China Isotope & Radiation Recent Development
Table 152. Jubilant Pharma Company Information
Table 153. Jubilant Pharma Introduction and Business Overview
Table 154. Jubilant Pharma Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Jubilant Pharma Radiopharmaceuticals Product
Table 156. Jubilant Pharma Recent Development
Table 157. Eli Lilly Company Information
Table 158. Eli Lilly Introduction and Business Overview
Table 159. Eli Lilly Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. Eli Lilly Radiopharmaceuticals Product
Table 161. Eli Lilly Recent Development
Table 162. Advanced Accelerator Applications Company Information
Table 163. Advanced Accelerator Applications Introduction and Business Overview
Table 164. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Advanced Accelerator Applications Radiopharmaceuticals Product
Table 166. Advanced Accelerator Applications Recent Development
Table 167. SIEMENS Company Information
Table 168. SIEMENS Introduction and Business Overview
Table 169. SIEMENS Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. SIEMENS Radiopharmaceuticals Product
Table 171. SIEMENS Recent Development
Table 172. Dongcheng Company Information
Table 173. Dongcheng Introduction and Business Overview
Table 174. Dongcheng Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 175. Dongcheng Radiopharmaceuticals Product
Table 176. Dongcheng Recent Development
Table 177. Navidea Company Information
Table 178. Navidea Introduction and Business Overview
Table 179. Navidea Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 180. Navidea Radiopharmaceuticals Product
Table 181. Navidea Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Radiopharmaceuticals Market Trends
Table 185. Radiopharmaceuticals Market Drivers
Table 186. Radiopharmaceuticals Market Challenges
Table 187. Radiopharmaceuticals Market Restraints
Table 188. Radiopharmaceuticals Distributors List
Table 189. Radiopharmaceuticals Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals Product Picture
Figure 2. Global Radiopharmaceuticals Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Radiopharmaceuticals Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Radiopharmaceuticals Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Diagnostic Radioisotopes
Figure 6. Global Diagnostic Radioisotopes Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Therapeutic Radioisotopes
Figure 8. Global Therapeutic Radioisotopes Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Radiopharmaceuticals Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Radiopharmaceuticals Sales Market Share by Type in 2022 & 2034
Figure 11. North America Radiopharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 12. North America Radiopharmaceuticals Sales Market Share in Value by Type in 2022
Figure 13. Europe Radiopharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 14. Europe Radiopharmaceuticals Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Radiopharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Radiopharmaceuticals Sales Market Share in Value by Type in 2022
Figure 17. Latin America Radiopharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Radiopharmaceuticals Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Radiopharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Radiopharmaceuticals Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceuticals Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceuticals Revenue in 2022
Figure 23. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Oncology
Figure 25. Global Oncology Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Cardiology
Figure 27. Global Cardiology Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Radiopharmaceuticals Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Radiopharmaceuticals Sales Market Share by Application in 2022 & 2034
Figure 32. North America Radiopharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 33. North America Radiopharmaceuticals Sales Market Share in Value by Application in 2022
Figure 34. Europe Radiopharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 35. Europe Radiopharmaceuticals Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Radiopharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Radiopharmaceuticals Sales Market Share in Value by Application in 2022
Figure 38. Latin America Radiopharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Radiopharmaceuticals Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Radiopharmaceuticals Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Radiopharmaceuticals Manufacturing Cost Structure
Figure 43. Radiopharmaceuticals Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries